Investeringsforeningen Wealth Invest
13.3.2026 09:00:00 CET | Globenewswire | Press release
Offentliggørelse af prospekter, Investeringsforeningen Wealth Invest
Offentliggørelse af prospekter, Investeringsforeningen Wealth Invest
Hermed offentliggøres ajourførte prospekter for de børsnoterede afdelinger i Investeringsforeningen Wealth Invest.
Prospekterne er ajourført med regnskabstal for 2025 samt estimater for løbende omkostninger og samlede transaktionsomkostninger for 2026.
Derudover er prospektet for Secure Spectrum afdelingerne blevet ajourført som følge af, at afdeling Secure Select Obligationer og Secure Select Aktier pr. dags dato oplyser efter artikel 8 i SFDR.
Der er ligeledes foretaget redaktionelle ændringer i en række af prospekterne.
Prospekterne er vedhæftet denne meddelelse og kan ligeledes tilgås via Foreningens hjemmeside.
For eventuelle spørgsmål kontakt Lise Bøgelund Jensen, direktør i foreningens investeringsforvaltningsselskab, på telefon 33 28 28 28.
Med venlig hilsen
Investeringsforeningen Wealth Invest
Attachments
- 2026 03 13 Prospekt WI HP Invest
- 2026 03 13 Prospekt WI AlphaCura 050100 AKL
- 2026 03 13 Prospekt WI I&T
- 2026 03 13 Prospekt WI Linde & Partners
- 2026 03 13 Prospekt WI Othania
- 2026 03 13 Prospekt WI Optimal
- 2026 03 13 Prospekt WI Secure Spectrum
- 2026 03 13 Prospekt WI TimeInvest
Documents
- 2026-03-13-prospekt-wi-hp-invest.pdf
- 2026-03-13-prospekt-wi-alphacura-050100-akl.pdf
- 2026-03-13-prospekt-wi-i-t.pdf
- 2026-03-13-prospekt-wi-linde-partners.pdf
- 2026-03-13-prospekt-wi-othania.pdf
- 2026-03-13-prospekt-wi-optimal.pdf
- 2026-03-13-prospekt-wi-secure-spectrum.pdf
- 2026-03-13-prospekt-wi-timeinvest.pdf
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
Idorsia Pharmaceuticals Ltd23.10.2026 17:45:00 CEST | Press release
Idorsia presents outstanding results with daridorexant in children and adolescents with insomnia and an expanding body of evidence in adults at Sleep Europe 2026
Novartis Pharma AG23.10.2026 17:45:00 CEST | Press release
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
Muck Rack23.10.2026 17:36:12 CEST | Press release
Muck Rack Named as a Leader in the 2026 First-Ever Gartner® Magic Quadrant™ for PR and Media Monitoring Tools
Norvault23.10.2026 16:29:06 CEST | Press release
NORVAULT AG extends Bacon Series 001 offer and tender timetable
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom